# A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity

> **NCT03922945** · PHASE4 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 223 (actual)

## Conditions studied

- Adolescent Obesity
- Obesity in Adolescence
- Adolescent Overweight

## Interventions

- **DRUG:** VI-0521 oral capsule
- **DRUG:** Placebo oral capsule
- **BEHAVIORAL:** Lifestyle Modification

## Key facts

- **NCT ID:** NCT03922945
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-02
- **Primary completion:** 2021-04-16
- **Final completion:** 2021-04-16
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2022-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03922945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03922945, "A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03922945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*